| pubmed-article:11812017 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11812017 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:11812017 | lifeskim:mentions | umls-concept:C0038250 | lld:lifeskim |
| pubmed-article:11812017 | lifeskim:mentions | umls-concept:C0035435 | lld:lifeskim |
| pubmed-article:11812017 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:11812017 | pubmed:dateCreated | 2002-1-28 | lld:pubmed |
| pubmed-article:11812017 | pubmed:abstractText | Animal models of autoimmune disease and case reports of patients with these diseases who have been involved in bone marrow transplants have provided important data implicating the haemopoietic stem cell in rheumatic disease pathogenesis. Animal and human examples exist for both cure and transfer of rheumatoid arthritis, systemic lupus erythematosus (SLE) and other organ-specific diseases using allogeneic haemopoietic stem cell transplantation. This would suggest that the stem cell in these diseases is abnormal and could be cured by replacement of a normal stem cell although more in vitro data are required in this area. Given the morbidity and increased mortality in some patients with severe autoimmune diseases and the increasing safety of autologous haemopoietic stem cell transplantation (HSCT), pilot studies have been conducted using HSCT in rheumatic diseases. It is still unclear whether an autologous graft will cure these diseases but significant remissions have been obtained which have provided important data for the design of randomized trials of HSCT versus more conventional therapy. Several trials are now open to accrual under the auspices of the European Bone Marrow Transplant Group/European League Against Rheumatism (EBMT/EULAR) registry. Future clinical and laboratory research will need to document the abnormalities of the stem cell of a rheumatic patient because new therapies based on gene therapy or stem cell differentiation could be apllied to these diseases. With increasing safety of allogeneic HSCT it is not unreasonable to predict cure of some rheumatic diseases in the near future. | lld:pubmed |
| pubmed-article:11812017 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11812017 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11812017 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11812017 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11812017 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:11812017 | pubmed:issn | 1521-6942 | lld:pubmed |
| pubmed-article:11812017 | pubmed:author | pubmed-author:BrooksPP | lld:pubmed |
| pubmed-article:11812017 | pubmed:author | pubmed-author:MooreJJ | lld:pubmed |
| pubmed-article:11812017 | pubmed:author | pubmed-author:TyndallAA | lld:pubmed |
| pubmed-article:11812017 | pubmed:copyrightInfo | Copyright 2001 Harcourt Publishers Ltd. | lld:pubmed |
| pubmed-article:11812017 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11812017 | pubmed:volume | 15 | lld:pubmed |
| pubmed-article:11812017 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11812017 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11812017 | pubmed:pagination | 711-26 | lld:pubmed |
| pubmed-article:11812017 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:11812017 | pubmed:meshHeading | pubmed-meshheading:11812017... | lld:pubmed |
| pubmed-article:11812017 | pubmed:meshHeading | pubmed-meshheading:11812017... | lld:pubmed |
| pubmed-article:11812017 | pubmed:meshHeading | pubmed-meshheading:11812017... | lld:pubmed |
| pubmed-article:11812017 | pubmed:meshHeading | pubmed-meshheading:11812017... | lld:pubmed |
| pubmed-article:11812017 | pubmed:meshHeading | pubmed-meshheading:11812017... | lld:pubmed |
| pubmed-article:11812017 | pubmed:meshHeading | pubmed-meshheading:11812017... | lld:pubmed |
| pubmed-article:11812017 | pubmed:meshHeading | pubmed-meshheading:11812017... | lld:pubmed |
| pubmed-article:11812017 | pubmed:meshHeading | pubmed-meshheading:11812017... | lld:pubmed |
| pubmed-article:11812017 | pubmed:year | 2001 | lld:pubmed |
| pubmed-article:11812017 | pubmed:articleTitle | Stem cells in the aetiopathogenesis and therapy of rheumatic disease. | lld:pubmed |
| pubmed-article:11812017 | pubmed:affiliation | Haematology Department, St Vincents Hospital, NSW, Australia. | lld:pubmed |
| pubmed-article:11812017 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11812017 | pubmed:publicationType | In Vitro | lld:pubmed |
| pubmed-article:11812017 | pubmed:publicationType | Review | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11812017 | lld:pubmed |
